Immunopharmacodynamic Profiles in Children With Renal Allografts Receiving Cyclosporine Therapy
- 1 August 1988
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 12 (2) , 104-109
- https://doi.org/10.1016/s0272-6386(88)80003-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- IN VITRO IMMUNOSUPPRESSIVE PROPERTIES OF CYCLOSPORINE METABOLITESTransplantation, 1987
- PHENOTYPE, ACTIVATION STATUS, AND SUPPRESSOR ACTIVITY OF HOST LYMPHOCYTES DURING ACUTE REJECTION AND AFTER CYCLOSPORINE-INDUCED UNRESPONSIVENESS OF RAT CARDIAC ALLOGRAFTSTransplantation, 1985
- IMMUNOPHARMACODYNAMIC EVALUATION OF CYCLOSPORINE-TREATED RENAL ALLOGRAFT RECIPIENTSTransplantation, 1984
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983
- HYPERBILIRUBINAEMIA AND CYCLOSPORIN A LEVELSThe Lancet, 1981
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- IMMUNOLOGICAL AND PHARMACOLOGICAL MONITORING IN THE CLINICAL USE OF CYCLOSPORIN AThe Lancet, 1981
- IMMUNE RESPONSES TO ORGAN ALLOGRAFTSTransplantation, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981